Viscontour® Serum Med in Hydration of Facial Skin

T

TRB Chemedica

Status

Completed

Conditions

Sodium Hyaluronate

Treatments

Device: Viscontour® Serum Med

Study type

Observational

Funder types

Industry

Identifiers

NCT03494140
VISCH-PMCF-DE-2016-09

Details and patient eligibility

About

The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.

Enrollment

40 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Females ≥ 18 years of age and in good general health condition
  2. Signed informed consent
  3. Existing Viscontour® Serum Med recommendation (i.a. for hydration, soothing, nourishing and refreshing the complexion and for use in combination with a day cream)

Exclusion criteria

  1. Known hypersensitivity to one of the Viscontour® Serum Med components
  2. Known pregnancy or lactating females
  3. Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
  4. Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems